Lacey, David L.
Amgen Incorporated,
United States
2025 Rank: 157353
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2772 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157353 | 183166 |
| Total Cites | 987 | 990 |
| H-index | 15 | 15 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 117 | 117 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 436 | 437 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 775 | 777 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.27 |
| Self-Citation Percentage |
0.30%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2024 Rank: 124630
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2364 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124630 | 141631 |
| Total Cites | 1099 | 1117 |
| H-index | 16 | 16 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 137 | 139 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 444 | 446 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 838 | 844 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.32 |
| Self-Citation Percentage |
1.61%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2023 Rank: 104406
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2195 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104406 | 118448 |
| Total Cites | 1301 | 1310 |
| H-index | 18 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 164 | 164 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 505 | 505 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 943 | 949 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.38 |
| Self-Citation Percentage |
0.69%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2022 Rank: 70565
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1709 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70565 | 83739 |
| Total Cites | 1505 | 1519 |
| H-index | 18 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 224 | 224 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 599 | 600 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1075 | 1085 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.40 |
| Self-Citation Percentage |
0.92%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2021 Rank: 81186
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1811 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81186 | 94475 |
| Total Cites | 2316 | 2346 |
| H-index | 22 | 22 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 325 | 325 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 905 | 905 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1664 | 1681 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.40 |
| Self-Citation Percentage |
1.28%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2020 Rank: 62160
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1350 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62160 | 71314 |
| Total Cites | 1936 | 1965 |
| H-index | 20 | 21 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 279 | 281 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 771 | 773 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1379 | 1395 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.41 |
| Self-Citation Percentage |
1.48%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.